Nebraska Strongest / Weakest Measures

Nebraska's Strongest Measures

Strongest Measures are those in which the State performed above the all-State average and are strongest among their measures relative to all reporting States. This State may be leading the way in quality in these measures.

The top five performing quality measures and the bottom five performing quality measures are listed here for Nebraska.

Historically, the State Snapshots have included State-specific estimates for selected AHRQ Quality Indicators (QIs) based on Healthcare Cost and Utilization Project (HCUP) data. The 2018 QDR does not include State-specific QI estimates based on 2016 HCUP data because the International Classification of Diseases, Tenth Revision, Clinical Modification/Procedure Coding System version of the QI software used did not include risk adjustment. State-specific QIs will be reported in future QDRs when the estimates can be risk adjusted.

Note: The best result for each measure can be either the highest or lowest value.

Strongest Measures
Measure Estimate Benchmark Distance to Benchmark
Drug overdose deaths involving any opioid per 100,000 resident population 3.1 4.0 Achieved: 23% better
Adults who had a doctor´s office or clinic visit in the last 12 months who sometimes or never got advice to quit smoking from provider, Medicare managed care 22.1 27.7 Achieved: 20% better
Drug overdose deaths involving natural and semisynthetic opioids per 100,000 resident population 1.7 1.9 Achieved: 10% better
Adults who needed to see a specialist in the last 12 months who sometimes or never found it easy to see a specialist, Medicare fee-for-service 6.7 7.2 Achieved: 8% better
Home health care patients whose pain when moving around decreased 76.1 73.8 Achieved: 3% better

Nebraska's Weakest Measures

Weakest Measures are those in which the State performed below the all-State average and are weakest among their measures relative to all reporting States. These measures highlight some of the opportunities for improvement.

Weakest Measures
Measure Estimate Benchmark Distance to Benchmark
Drug overdose deaths involving other synthetic opioids (other than methadone) per 100,000 resident population 1.3 0.7 78%
Home health care patients who had an emergency department visit without a hospitalization 5.1 2.9 79%
Long-stay nursing home patients experiencing one or more falls with major injury 0.9 0.4 132%
Long-stay nursing home residents with moderate to severe pain 12.1 4.7 157%
Long-stay nursing home residents have depressive symptoms 4.4 1.1 283%

State’s performance on all measures is available on the Quality Measures Compared to Achievable Benchmarks.